2016 Archives
You are viewing archived information from 2016
| Measure Title: |
RELATING TO PAIN MANAGEMENT.
|
| Report Title: |
Pain Management; Narcotics Enforcement; Continuing Medical Education; Pain Medication Agreement; Uniform Controlled Substances Act; Medical Immunity; Appropriation ($)
|
| Description: |
Part I: Establishes the Hawaii drug take-back and education initiative and the narcotics enforcement and prescription drug monitoring advisory committee. Part II: Establishes the narcotics advisory committee to recommend topics and curriculum for the continuing medical education program. Establishes requirements for a continuing medical education program for prescribing practitioners that prescribe narcotic drugs. Part III: Requires a pain medication agreement to be executed between a patient and any prescriber of a narcotic drug within the State for use as pain medication under certain conditions. Requires the administrator of the narcotics enforcement division to develop and make available a template of the agreement. Part IV: Requires practitioners to register to use the electronic prescription accountability system (EPAS) to administer, prescribe, or dispense a controlled substance. Requires all practitioners prescribing or dispensing certain controlled substances to use EPAS beginning 1/1/2016. Requires all practitioners and practitioner delegates to request patient information from the central repository prior to prescribing or dispensing a controlled substance to a new patient and any patient receiving chronic pain therapy beginning 1/1/2017. Provides pharmacist delegates and practitioner delegates with access to EPAS and in certain situations, expands access to investigative information in EPAS to include law enforcement officers and investigative agents of regulatory agencies and various individuals. Part V: Creates immunity for individuals who prescribe, possess, or administer an opioid antagonist during an opioid-related drug overdose. Authorizes emergency personnel to administer naloxone hydrochloride. Requires medicaid coverage for naloxone hydrochloride. Exempts pharmacists and pharmacies from certain licensure and permitting requirements. Appropriates funds for drug overdose recognition, prevention, and response.
|
| Companion: |
|
| Package: |
None
|
| Current Referral: |
CPH/PSM/JDL, WAM
|
| Introducer(s): |
GREEN
|
| Act: |
|
| Sort by Date | | Status Text |
| 1/21/2016 | S | Re-Referred to CPH/PSM/JDL, WAM. |
| 12/17/2015 | D | Carried over to 2016 Regular Session. |
| 2/11/2015 | S | The committee on HTH/PSM/JDL deferred the measure. |
| 2/6/2015 | S | The committee(s) on HTH/PSM/JDL has scheduled a public hearing on 02-11-15 1:20PM in conference room 414. |
| 1/29/2015 | S | Referred to HTH/PSM/JDL, CPN/WAM. |
| 1/29/2015 | S | Passed First Reading. |
| 1/29/2015 | S | Introduced. |
S = Senate |
H = House |
D = Data Systems |
$ = Appropriation measure |
ConAm = Constitutional Amendment
Some of the above items require Adobe Acrobat Reader. Please visit
Adobe's download page
for detailed instructions.
SB1229
No other committee reports available at this time.
You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.